You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Valiant™ Captivia Stent Graft with the Captivia™ Delivery System
Valiant™ Captivia Stent Graft with the Captivia™ Delivery System
Download Brochure
Proven design and performance offer a broad set of options to treat a wide range of patient anatomies. With more than 100,000 patients treated worldwide, the Valiant™ Captivia™ stent graft system is designed to treat all lesions of the descending thoracic aorta, including thoracic aortic aneurysms (TAA), type B aortic dissection (TBAD), intramural hematoma (IMH), penetrating atherosclerotic (PAU), and blunt thoracic aortic injury (BTAI).
The Valiant™ thoracic stent graft with the Captivia™ delivery system is indicated for treatment of diseases of the descending thoracic aorta, including but not limited to, aneurysms and dissections. The Valiant thoracic stent graft is indicated for exclusion of the aneurysm, the false lumen or site of rupture, and restoration of blood flow through the stent graft lumen. The device is intended for use in patients who are candidates for conventional surgical repair, and in patients who are not candidates for conventional surgical repair due to pre-existing risk factors.
Valiant™ Captivia™ thoracic stent graft system maintains vessel wall apposition and fixation, regardless of angulation and oversizing.1 Clinically supported by low type Ia endoleak rate (0% at 5 years).2 The stent graft system has over a decade of worldwide experience and has been chosen for over 150,000† patients worldwide. It has five years of clinical data across all descending thoracic aortic pathologies.2–4
Case image courtesy of Dr. Roy M. Fujitani, M.D.
Dr. Jean Panneton Conformability Video - (03:07)
Watch this video and hear Dr. Panneton discuss how Valiant Captivia is highly flexible and conformable due to its sinusoidal shape, super‑elastic nitinol springs, and lack of a longitudinal bar.
More information (see more)
Less information (see less)
Dr. Hitoshi Matsuda Dissection Video - (02:10)
Watch this video and hear Dr. Matsuda review a type B aortic dissection case he treated with TEVAR, which provides a minimally invasive alternative to open surgical repair.
More information (see more)
Less information (see less)
How does Valiant™ Captivia™ system maintain a continuous seal in a dynamic environment?
Slow, controlled deployment for precise placement
Quick deployment option, if desired
Tip capture release
Find this technical manual in the Medtronic Manual Library, in the product labeling supplied with each device.
Use this tool to plan case specifics such as sizing and placement.
See model specs including stent graft lengths, diameters, tapers, and crossing profiles.
View presentations and videos, and find other educational resources.
Discover education1. Canaud L, Cathala P, Joyeux F, Branchereau P, Marty-Ané C, Alric P. Improvement in conformability of the latest generation of thoracic stent grafts. J Vasc Surg. 2013;57(4):1084–1089. doi: 10.1016/j.jvs.2012.09.019
2. Conrad MF, Tuchek J, Freezor R, Bavaria J, White R, Fairman R. Results of the VALOR II trial of the Medtronic Valiant thoracic stent graft. J Vasc Surg. 2017;66(2):335–342. doi: 10.1016/j.jvs.2016.12.136.
3. Bavaria JE, Brinkman WT, Hughes GC, et al. Five-year outcomes of endovascular repair of complicated acute type B aortic dissections. J Thorac Cardiovas Surg. 2022;163(2):539–548.e2. doi: 10.1016/j.jtcvs.2020.03.162.
4. Patal HJ, Azizzadeh A, Matsumoto AH, et al. Five-year outcomes from the United States pivotal trial of Valiant Captivia stent graft for blunt aortic injury. Ann Thorac Surg. 2020;110(3):815–820. doi: 10.1016/j.athoracsur.2019.12.028.